CDNA
CDNA
NASDAQ · Biotechnology

Caredx Inc

$26.03
+0.91 (+3.62%)
As of Jun 24, 2:10 PM ET ·
Financial Highlights (FY 2026)
Revenue
392.17M
Net Income
-22,047,387
Gross Margin
67.5%
Profit Margin
-5.6%
Rev Growth
+5.7%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.5% 67.5% 39.5% 39.5%
Operating Margin -8.1% -7.3% -17.7% -19.5%
Profit Margin -5.6% -5.3% -18.5% -18.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 392.17M 371.09M 329.37M 271.09M
Gross Profit 264.91M 250.67M 130.20M 107.16M
Operating Income -31,765,817 -27,052,645 -58,208,720 -52,994,442
Net Income -22,047,387 -18,776,162 -60,795,749 -51,228,951
Gross Margin 67.5% 67.5% 39.5% 39.5%
Operating Margin -8.1% -7.3% -17.7% -19.5%
Profit Margin -5.6% -5.3% -18.5% -18.9%
Rev Growth +5.7% +5.7% -9.3% +22.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 344.44M 346.18M
Total Equity 455.35M 445.81M
D/E Ratio 0.76 0.78
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -29,095,729 -26,155,320 -79,903,104 -63,531,119
Free Cash Flow -60,969,564 -57,293,986